Cibc Private Wealth Group, LLC Intellia Therapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $52.7 Billion
- Q4 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 4,611 shares of NTLA stock, worth $49,337. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,611
Previous 8,382
44.99%
Holding current value
$49,337
Previous $172,000
69.19%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding NTLA
# of Institutions
336Shares Held
91MCall Options Held
1MPut Options Held
728K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.5MShares$134 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$109 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$103 Million0.0% of portfolio
-
State Street Corp Boston, MA5.21MShares$55.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.81MShares$40.8 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $813M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...